Azilsartan D5 is a deuterated variant of the active pharmaceutical ingredient azilsartan, in which five hydrogen atoms are replaced with deuterium. It is primarily used as a research compound in pharmaceutical development.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1346599-45-8
6-methylrisperidone
pharmaceutical raw material
4-Chloro Perazine Dihydrochloride
pharmaceutical raw material
Ent-Moxifloxacin Hydrochloride
pharmaceutical raw material
N-Desmethyl Almotriptan-d3
pharmaceutical raw material
Azilsartan
pharmaceutical raw material
1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid ethyl ester
pharmaceutical intermediate
1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester
pharmaceutical intermediate
3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]-2-(1,1,2,2,2-pentadeuterioethoxy)benzimidazole-4-carboxylic acid
KGSXMPPBFPAXLY-ZBJDZAJPSA-N
[2H]C([2H])([2H])C([2H])([2H])OC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O